HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mendez, A. J. Articles by Uint, L. Search for Related Content PubMed PubMed Citation Articles by Mendez, A. J. Articles by Uint, L. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 37, 2510-2524, Copyright © 1996 by Lipid Research, Inc.

ARTICLES

Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus

AJ Mendez and L Uint
Cardiac Unit (GRJ-1422), Massachusetts General Hospital, Boston 02114, USA.

Several studies have demonstrated that lipid-free apolipoproteins can promote cholesterol and phospholipid efflux from cells; however, the mechanisms and the role of cell-mediated pathways involved remain incompletely elucidated. We have recently demonstrated that brefeldin A or monensin, agents that disrupt Golgi apparatus structure and function, inhibit intracellular cholesterol efflux from cells to high density lipoproteins. In the present study we examined the effects of those agents on cell cholesterol and phospholipid efflux to purified apolipoprotein A-I (apoA-I) and apolipoprotein-depleted acceptors from cholesterol-loaded fibroblasts. Brefeldin A or monensin treatment of cells during incubation with apoA-I inhibited efflux of cellular cholesterol by greater than 80% compared with control cells, measured by changes in cellular cholesterol radioactivity, mass, and the substrate pool of cholesterol available for esterification by acyl coenzyme A:cholesterol acyltransferase. Inhibition of cholesterol efflux by these agents could not be overcome by increasing the apoA-I concentration and persisted during incubations up to 24 h. Similarly, brefeldin A and monensin inhibited up to 80% of apoA-I-mediated efflux of labeled phospholipids from cholesterol-loaded cells relative to controls. In contrast, lipid efflux mediated by apolipoprotein-depleted acceptors (trypsin-modified HDL and sonicated phospholipid vesicles) was not sensitive to these drugs. On the basis the known effects of brefeldin A and monensin on Golgi apparatus structure and function, these results are consistent with the notion that efflux of cell lipids by apolipoprotein-dependent mechanisms, but not by apolipoprotein- independent mechanisms, require active cellular processes involving an intact and functional Golgi apparatus.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. E. Faulkner, S. E. Panagotopulos, J. D. Johnson, L. A. Woollett, D. Y. Hui, S. R. Witting, J. N. Maiorano, and W. S. Davidson An analysis of the role of a retroendocytosis pathway in ABCA1-mediated cholesterol efflux from macrophages J. Lipid Res., June 1, 2008; 49(6): 1322 - 1332. [Abstract] [Full Text] [PDF]

				G. Dagher, N. Donne, C. Klein, P. Ferre, and I. Dugail HDL-mediated cholesterol uptake and targeting to lipid droplets in adipocytes J. Lipid Res., October 1, 2003; 44(10): 1811 - 1820. [Abstract] [Full Text] [PDF]

				X. Zha, A. Gauthier, J. Genest, and R. McPherson Secretory Vesicular Transport from the Golgi Is Altered during ATP-binding Cassette Protein A1 (ABCA1)-mediated Cholesterol Efflux J. Biol. Chem., March 14, 2003; 278(12): 10002 - 10005. [Abstract] [Full Text] [PDF]

				W. S. Garver, K. Krishnan, J. R. Gallagos, M. Michikawa, G. A. Francis, and R. A. Heidenreich Niemann-Pick C1 protein regulates cholesterol transport to the trans-Golgi network and plasma membrane caveolae J. Lipid Res., April 1, 2002; 43(4): 579 - 589. [Abstract] [Full Text] [PDF]

				C. P. Sparrow, J. Baffic, M.-H. Lam, E. G. Lund, A. D. Adams, X. Fu, N. Hayes, A. B. Jones, K. L. Macnaul, J. Ondeyka, et al. A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux J. Biol. Chem., March 15, 2002; 277(12): 10021 - 10027. [Abstract] [Full Text] [PDF]

				R. Arakawa, S. Abe-Dohmae, M. Asai, J.-i. Ito, and S. Yokoyama Involvement of caveolin-1 in cholesterol enrichment of high density lipoprotein during its assembly by apolipoprotein and THP-1 cells J. Lipid Res., December 1, 2000; 41(12): 1952 - 1962. [Abstract] [Full Text]

				M. E. Brousseau, G. P. Eberhart, J. Dupuis, B. F. Asztalos, A. L. Goldkamp, E. J. Schaefer, and M. W. Freeman Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size J. Lipid Res., July 1, 2000; 41(7): 1125 - 1135. [Abstract] [Full Text]

				W. S. Garver, R. A. Heidenreich, R. P. Erickson, M. A. Thomas, and J. M. Wilson Localization of the murine Niemann-Pick C1 protein to two distinct intracellular compartments J. Lipid Res., May 1, 2000; 41(5): 673 - 687. [Abstract] [Full Text]

				M. E. Brousseau, E. J. Schaefer, J. Dupuis, B. Eustace, P. Van Eerdewegh, A. L. Goldkamp, L. M. Thurston, M. G. FitzGerald, D. Yasek-McKenna, G. O'Neill, et al. Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds J. Lipid Res., March 1, 2000; 41(3): 433 - 441. [Abstract] [Full Text]

				S Prattes, G Horl, A Hammer, A Blaschitz, W. Graier, W Sattler, R Zechner, and E Steyrer Intracellular distribution and mobilization of unesterified cholesterol in adipocytes: triglyceride droplets are surrounded by cholesterol-rich ER-like surface layer structures J. Cell Sci., January 9, 2000; 113(17): 2977 - 2989. [Abstract] [PDF]

				J. F. Oram, A. J. Mendez, J. Lymp, T. J. Kavanagh, and C. L. Halbert Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: lack of effect with Tangier disease cells J. Lipid Res., October 1, 1999; 40(10): 1769 - 1781. [Abstract] [Full Text]

				Y. Takahashi and J. D. Smith Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway PNAS, September 28, 1999; 96(20): 11358 - 11363. [Abstract] [Full Text] [PDF]

				T. A. Lagace, D. M. Byers, H. W. Cook, and N. D. Ridgway Chinese hamster ovary cells overexpressing the oxysterol binding protein (OSBP) display enhanced synthesis of sphingomyelin in response to 25-hydroxycholesterol J. Lipid Res., January 1, 1999; 40(1): 109 - 116. [Abstract] [Full Text]

				M. Marcil, L. Yu, L. Krimbou, B. Boucher, J. F. Oram, J. S. Cohn, and J. Genest Jr Cellular Cholesterol Transport and Efflux in Fibroblasts Are Abnormal in Subjects With Familial HDL Deficiency Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 159 - 169. [Abstract] [Full Text] [PDF]

				K. L. Gillotte, W. S. Davidson, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips Removal of cellular cholesterol by pre-ß-HDL involves plasma membrane microsolubilization J. Lipid Res., October 1, 1998; 39(10): 1918 - 1928. [Abstract] [Full Text]

				G. P. Eberhart, A. J. Mendez, and M. W. Freeman Decreased Cholesterol Efflux from Fibroblasts of a Patient without Tangier Disease, but with Markedly Reduced High Density Lipoprotein Cholesterol Levels J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 836 - 846. [Abstract] [Full Text]

				A. J. Mendez, G. Lin, D. P. Wade, R. M. Lawn, and J. F. Oram Membrane Lipid Domains Distinct from Cholesterol/Sphingomyelin-Rich Rafts Are Involved in the ABCA1-mediated Lipid Secretory Pathway J. Biol. Chem., January 26, 2001; 276(5): 3158 - 3166. [Abstract] [Full Text] [PDF]